Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CEREVEL THERAPEUTICS HOLDINGS, INC.

(CERE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
21.39(c) 22.48(c) 24.29(c) 24.99(c) 24.67(c) Last
590 196 727 067 978 798 847 198 372 425 Volume
+0.61% +5.10% +8.05% +2.88% -1.28% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -215 M - -
Net cash position 2021 395 M - -
P/E ratio 2021 -15,1x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -252 M - -
Net cash position 2022 459 M - -
P/E ratio 2022 -13,7x
Yield 2022 -
Capitalization 3 490 M 3 490 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 104
Free-Float 78,4%
More Financials
Company
Cerevel Therapeutics Holdings, Inc is a clinical-stage biopharmaceutical company. The Company combines understanding of the biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) receptor pharmacology to discover and develop new therapies. The Company has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with... 
More about the company
All news about CEREVEL THERAPEUTICS HOLDINGS, INC.
07/22CEREVEL THERAPEUTICS : to Report Second Quarter 2021 Financial Results on Wednes..
AQ
07/13CEREVEL THERAPEUTICS : Stifel Adjusts Price Target on Cerevel Therapeutics Holdi..
MT
07/02CEREVEL THERAPEUTICS : Announces Pricing of $350 Million Public Offering of Comm..
PU
07/02CEREVEL THERAPEUTICS HOLDINGS, INC. : Other Events, Financial Statements and Exh..
AQ
07/02CEREVEL THERAPEUTICS : Prices Common Stock Offering at $25 Per Share
MT
06/30SECTOR UPDATE : Health Care Stocks Mostly Treading Water Near Wednesday Close
MT
06/30CEREVEL THERAPEUTICS : Stock Drops 11% on Public Offering of 14 Million Shares
MT
06/30SECTOR UPDATE : Health Care Stocks Slip as Biotechs Rally
MT
06/29CEREVEL THERAPEUTICS : to Sell 14 Million Shares in Public Offering
MT
06/29SECTOR UPDATE : Health Care Stocks Still Listless Near Session's End
MT
06/29SECTOR UPDATE : Health Care Stocks Managing Slight Gains
MT
06/29SECTOR UPDATE : Health Care Stocks Flat To Higher Premarket Tuesday
MT
06/29Wall Street in Holding Pattern Pre-Bell, Consumer Confidence Data on Tap
MT
06/29CEREVEL THERAPEUTICS : Says Phase 1b Clinical Trial of Schizophrenia Drug Candid..
MT
06/29CEREVEL THERAPEUTICS : Announces Positive Topline Results for CVL-231 in Phase 1..
PU
More news
News in other languages on CEREVEL THERAPEUTICS HOLDINGS, INC.

- No features available -

More news
Analyst Recommendations on CEREVEL THERAPEUTICS HOLDINGS, INC.
More recommendations
Chart CEREVEL THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Cerevel Therapeutics Holdings, Inc. Technical Analysis Chart | CERE | US15678U1280 | MarketScreener
Technical analysis trends CEREVEL THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 24,67 $
Average target price 28,00 $
Spread / Average Target 13,5%
EPS Revisions
Managers and Directors
N. Anthony Coles Executive Chairman & Chief Executive Officer
Abraham N. Ceesay President
Kathy Yi Chief Financial Officer
John Renger Chief Scientific Officer
Raymond Sanchez Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CEREVEL THERAPEUTICS HOLDINGS, INC.48.79%1 652
GILEAD SCIENCES, INC.18.47%85 134
WUXI APPTEC CO., LTD.37.17%71 226
REGENERON PHARMACEUTICALS21.37%57 013
BIONTECH SE245.88%55 555
VERTEX PHARMACEUTICALS-15.16%50 308